These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 27430664)
41. Gel-based proteomics analysis of the heterogeneity of 20S proteasomes from four human pancreatic cancer cell lines. Wang X; Zhao Z; Luo Y; Chen G; Li Z Proteomics Clin Appl; 2011 Oct; 5(9-10):484-92. PubMed ID: 21751412 [TBL] [Abstract][Full Text] [Related]
42. The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms. Winkler LL; Kalejta RF J Virol; 2014 Oct; 88(20):11782-90. PubMed ID: 25078702 [TBL] [Abstract][Full Text] [Related]
43. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. Qiu XB; Ouyang SY; Li CJ; Miao S; Wang L; Goldberg AL EMBO J; 2006 Dec; 25(24):5742-53. PubMed ID: 17139257 [TBL] [Abstract][Full Text] [Related]
44. [The key role of the regulatory 19S subunit in changes in the brain proteasome subproteome induced by the neuroprotector isatin]. Buneeva OA; Kopylov AT; Medvedev AE Biomed Khim; 2022 Aug; 68(4):250-262. PubMed ID: 36005843 [TBL] [Abstract][Full Text] [Related]
45. A quantitative proteomic approach using two-dimensional gel electrophoresis and isotope-coded affinity tag labeling for studying human 20S proteasome heterogeneity. Froment C; Uttenweiler-Joseph S; Bousquet-Dubouch MP; Matondo M; Borges JP; Esmenjaud C; Lacroix C; Monsarrat B; Burlet-Schiltz O Proteomics; 2005 Jun; 5(9):2351-63. PubMed ID: 15887188 [TBL] [Abstract][Full Text] [Related]
46. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511 [TBL] [Abstract][Full Text] [Related]
47. Affinity labeling of the proteasome by a belactosin A derived inhibitor. Hasegawa M; Kinoshita K; Nishimura C; Matsumura U; Shionyu M; Ikeda S; Mizukami T Bioorg Med Chem Lett; 2008 Oct; 18(20):5668-71. PubMed ID: 18801655 [TBL] [Abstract][Full Text] [Related]
48. ECPAS/Ecm29-mediated 26S proteasome disassembly is an adaptive response to glucose starvation. Choi WH; Yun Y; Byun I; Kim S; Lee S; Sim J; Levi S; Park SH; Jun J; Kleifeld O; Kim KP; Han D; Chiba T; Seok C; Kwon YT; Glickman MH; Lee MJ Cell Rep; 2023 Jul; 42(7):112701. PubMed ID: 37384533 [TBL] [Abstract][Full Text] [Related]
49. Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography method. Scanlon TC; Gottlieb B; Durcan TM; Fon EA; Beitel LK; Trifiro MA Exp Cell Res; 2009 Jan; 315(2):176-89. PubMed ID: 19013454 [TBL] [Abstract][Full Text] [Related]
50. Global organization and function of mammalian cytosolic proteasome pools: Implications for PA28 and 19S regulatory complexes. Shibatani T; Carlson EJ; Larabee F; McCormack AL; Früh K; Skach WR Mol Biol Cell; 2006 Dec; 17(12):4962-71. PubMed ID: 16987959 [TBL] [Abstract][Full Text] [Related]
51. Proteomics to study the diversity and dynamics of proteasome complexes: from fundamentals to the clinic. Bousquet-Dubouch MP; Fabre B; Monsarrat B; Burlet-Schiltz O Expert Rev Proteomics; 2011 Aug; 8(4):459-81. PubMed ID: 21819302 [TBL] [Abstract][Full Text] [Related]
52. Proteome dynamics and proteome function of cardiac 19S proteasomes. Wang D; Zong C; Koag MC; Wang Y; Drews O; Fang C; Scruggs SB; Ping P Mol Cell Proteomics; 2011 May; 10(5):M110.006122. PubMed ID: 21357515 [TBL] [Abstract][Full Text] [Related]
53. Post-translationally modified S12, absent in transformed breast epithelial cells, is not associated with the 26S proteasome and is induced by proteasome inhibitor. Thompson HG; Harris JW; Brody JP Int J Cancer; 2004 Sep; 111(3):338-47. PubMed ID: 15221960 [TBL] [Abstract][Full Text] [Related]
54. An engineered cell line with a hRpn1-attached handle to isolate proteasomes. Negi H; Osei-Amponsa V; Ibrahim B; Evans CN; Sullenberger C; Loncarek J; Chari R; Walters KJ J Biol Chem; 2023 Aug; 299(8):104948. PubMed ID: 37354974 [TBL] [Abstract][Full Text] [Related]
55. Circulating extracellular proteasome in the cerebrospinal fluid: a study on concentration and proteolytic activity. Mueller O; Anlasik T; Wiedemann J; Thomassen J; Wohlschlaeger J; Hagel V; Keyvani K; Schwieger I; Dahlmann B; Sure U; Sixt SU J Mol Neurosci; 2012 Mar; 46(3):509-15. PubMed ID: 21881828 [TBL] [Abstract][Full Text] [Related]
57. Structure and functions of the 20S and 26S proteasomes. Coux O; Tanaka K; Goldberg AL Annu Rev Biochem; 1996; 65():801-47. PubMed ID: 8811196 [TBL] [Abstract][Full Text] [Related]
59. Proteasome Interactome and Its Role in the Mechanisms of Brain Plasticity. Buneeva OA; Kopylov AT; Medvedev AE Biochemistry (Mosc); 2023 Mar; 88(3):319-336. PubMed ID: 37076280 [TBL] [Abstract][Full Text] [Related]
60. Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failure. Day SM; Divald A; Wang P; Davis F; Bartolone S; Jones R; Powell SR Circ Heart Fail; 2013 May; 6(3):544-9. PubMed ID: 23515276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]